PEDIATRICS Vol. 119 No. 2 February 2007, pp. e419-e425 (doi:10.1542/peds.2006-1862)
ARTICLE |
Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin
a Departments of Child Health
b Cardiology, University of Ioannina, Ioannina, Greece
c Department of Pediatrics, University Hospital of Ioannina, Ioannina, Greece
OBJECTIVE. Although nitroglycerin- and isoproterenol-augmented tilt tests are of equal value in the diagnosis of neurocardiogenic syncope in adults, no data exist in children. We compared the sensitivity and specificity of the 2 tests in a pediatric population.
PATITENS AND METHODS. We studied 85 patients (33 boys; mean age: 11.6 ± 2.9 years). Of them, 56 had a diagnostic history of neurocardiogenic syncope, whereas 29 served as controls. After a negative passive phase, they were randomly assigned to either intravenous isoproterenol or sublingual nitroglycerin, and tilt was continued for 20 minutes.
RESULTS. Sensitivity was 0.78 for the isoproterenol test and 0.79 for the nitroglycerin test, but specificity was significantly higher for isoproterenol test compared with nitroglycerin test. In patients with a positive test, the duration of the recovery period was significantly longer after nitroglycerin (8.4 ± 2.7 minutes) than after isoproterenol (5.1 ± 1.6 minutes).
CONCLUSIONS. Nitroglycerin- and isoproterenol-augmented tilt tests are associated with equal sensitivity in the diagnosis of neurocardiogenic syncope in children and adolescents. However, nitroglycerin results in more false-positive tests and produces more prolonged vasovagal symptoms. Our data do not support the routine use of nitroglycerin in the evaluation of syncope in this age group.
Key Words: neurocardiogenic syncope tilt test children isoproterenol nitroglycerin
Abbreviations: CIconfidence interval
Accepted Aug 30, 2006.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), Endorsed by the following societies, European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC) Eur. Heart J., November 1, 2009; 30(21): 2631 - 2671. [Full Text] [PDF] |
||||
![]() |
G. Foglia-Manzillo and F. Giada Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope: reply Eur. Heart J., April 2, 2008; 29(8): 1075 - 1075. [Full Text] [PDF] |
||||
![]() |
E. Jastrzebska-Maj, K. Mizia-Stec, and D. Jakubowski Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope Eur. Heart J., April 2, 2008; 29(8): 1074 - 1075. [Full Text] [PDF] |
||||





